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Abstract:
Background: Hepatitis viral infections are major health challenge leading to high morbidity and mortality world-
wide.
Objectives:  Although  the  magnitude  of  hepatitis  in Pakistan  has been well  documented, information  regard-
ing  the prevalence  of  hepatitis  C virus  (HCV)  infection  in Faisalabad, Pakistan is scarce. The present retrospec-
tive study was undertaken to determine the epidemiology of  HCV in Faisalabad, Pakistan.
Methods:  Between  May,  2010  and  December,  2012,  medical  records  of   39780  subjects visiting sexually 
transmitted infections (STIs) clinic, district headquarter (DHQ) hospital, Faisalabad, Pakistan were reviewed. Re-
gression analysis was used to determine independent risk factors
Results: HCV prevalence was 21.99%. With mean age of  49.5 ± 2.7 years (range 27-63 years), majority (67.15%) 
of  the individuals were male. Marital status and low literacy rates were associated with HCV (P<0.05). Reference 
to the potential risk factors, the injection drug use was the major mode (72.77%) of  infection transmission. Age 
(OR 1.5, 95% CI 1.2-1.9), male gender (OR 1.2, 95% CI 0.9-1.6) and injection use (OR 1.9, 95% CI 1.0-2.7) were 
significantly associated with HCV.
Conclusions:  Most important finding was higher HCV prevalence in Faisalabad region as compared to  the  pre-
vious   assessments   that  demands   an  urgent   need  for  preventive intervention strategies.
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Introduction
Hepatitis C viral infections are major health challenge, 
with the global prevalence  of  180  million patients. In 
Pakistan, about one million people are inflicted with 
hepatitis C virus (HCV). It leads to liver cirrhosis or 
hepatocellular carcinoma and results in high morbidity 
and mortality. 1-3 Nelson et al.,4 compiled data on hepa-
titis prevalence in intravenous drug users (IDU) and it 
was observed that 60-80% of  IDUs had anti-HCV in 
25 countries and about 10.0 million  IDUs  worldwide   
might be  anti-HCV  positive.  Numerous studies  docu-
mented prevalence  of  hepatitis C infection.5-17  
Diverse HCV prevalence  rates worldwide  could be ex-
plained by the different risk factors involved.18-20 At 
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national level, HCV prevalence among general popula-
tion and high risk groups was reported.21-24   Ahmed et 
al.,25  reported  16% HCV prevalence  among subjects 
visiting HCV screening camps and blood donors in 
Faisalabad. HCV infection inflicts major socioeconom-
ic  burdens  and effective  intervention  strategies  are 
mandatory  to combat  the consequences of  hepatitis C 
at the regional levels.1,24,25 
Incidence  estimates  are  prerequisite  to  lessen  the 
disease  burden,  hence  preventive  and treatment 
strategies can be implemented with precise objectives 
set to be attained. Despite increasing reports of  HCV 
infections, its incidence and risk factors in Faisalabad, 
Pakistan are still obscure. Present retrospective study 
was undertaken to determine the epidemiology of  viral 
hepatitis C in the local population. 
                                                       
Methods
Study Period and Data Collection
The  study  covered  two  and a half   year  period  from 
May,  2010 to December,  2012  and included 39780 
individuals visiting STIs clinic, DHQ hospital, Faisal-
abad, Pakistan. From Clinical Pathology Laboratory 
(CPL), District Headquarter hospital, Faisalabad, Paki-
stan, patients’ records were procured. As per reports; 
routine investigation involved blood sera test for  an-
tibodies   to  HCV  (anti-HCV)   by  enzyme   linked 
immunosorbent   assay  (Abbot Diagnostics, Germany), 
in accordance with the manufacturer’s instructions. In 
addition, the following information was also collected: 
age, gender, marital status, education and high risk be-
haviours (blood donation, intravenous drugs abuse and 
sexual behaviours). The study was anonymous.  Ethical 
approval  for  the  protocols  was  procured  from  Re-
search  Committee, Punjab Medical College, Faisalabad, 
Pakistan.
All the data were expressed as number (n) or mean 
(standard error). Potential risk factors were assessed by 
multivariate analysis of  variance (MANOVA). The p 
value of  less than 0.05 was considered  to be significant. 
To estimate the effect of  each risk factor on anti-HCV
positivity, the odds ratio was calculated by logisticre-
gressionanalysis. Statistical analysis was performed by 
Statistical Package for the Social Sciences (SPSS Inc. 
Chicago, IL, USA) software (version 15.0) 
 
Results
The present retrospective study was conducted with the 
aim to assess the HCV prevalence rate and the risk fac-
tors in general population visiting DHQ hospital, Fais-
alabad, Pakistan. Overall HCV prevalence  was 21.99% 
(8751/39780)  of  the total sample. Annual  incidence 
rates of  HCV as shown in table 1 were almost consist-
ent over the study period.
Comparative analysis of  data regarding anti-HCV posi-
tive and anti-HCV negative subjects is summarized in 
table 2. Reference to the baseline characteristics of  the 
HCV positive subjects, the mean age of  the positive 
sample was 49.5 ± 2.73 years, signifying the fact that risk 
of  HCV increased with older age. Majority (67.15%) of  
the HCV-positive individuals were male and the HCV 
seroprevalence showed statistically significant differ-
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Data are number (N), percentage (%) or mean (standard error). * P < 0.05a Self-reported extra-marital.
Table 1: Year-wise prevalence of  HCV
      2010                               2011                                    2012                        Overall Prevalence
Tested      Positive               Tested Positive            Tested       Positive            Tested Positive
                         (%)                                     (%)                                     (%)                                        (%)
11290     1887 (16.71)      13354 3360 (25.16) 15136      3504 (23.15)     39780 8751 (21.99)
Data are n (%)
CI: Confidence interval, OR: odds ratio (derived by multiple logistic regression analysis. Each variable is adjusted for the confounding 
effect of  all the others listed in the table).
ences (P<0.05) between the two genders. Of  potential 
risk factors, the injection usage was the major mode 
(72.77%) of  infection  transmission.  Contrary  to  that, 
gender  disparity  was  less  prominent  in  HCV- nega-
tive individuals. The majority of  the case participants 
(83.29%) were married and about 86% had primary lev-
el education. In anti-HCV negative group, only about 
half  of  the sample was married and 46.64% had higher 
education (>primary level). In anti-HCV subjects, about 
60% denied any involvement in blood donation activity. 
Majority of  the people in this group contradicted the 
drugs injection practice and extra-marital sexual activi-
ties. Table 3 shows the results of  regression model to 
estimate the effect of  each exposure while controlling 
for all other  variables.  Multivariate  regression  was 
used  to  estimate  independent  effects  of   risk factors 
on  seropositivity.   Among  those,  the  following  risk 
factors  were  significantly associated with seropositiv-
ity: over 40 years of  age (OR 1.5, 95% CI 1.2-1.9); male 
gender (OR 1.2, 95% CI 0.9-1.6) and injection use (OR 
1.9, 95% CI 1.0-2.7). Age (P 0.03) and male gender (P 
0.004) were strongly associated with anti-HCV. Injec-
tion use increased the odds of  being anti-HCV–positive 
(P 0.002). In regression model, education and marital 
status were no longer the significant predictors. 
Discussion
The epidemiology  of  HCV may be diverse among dif-
ferent ethnic groups and within the same  ethnic  group 
residing  in different  geographic  area.  Present  study 
estimated  that the prevalence of  HCV in Faisalabad re-
gion was 21.99% (table 1) which was a little higher than 
the earlier reported 16% HCV prevalence25.  Different 
rates can be justified by the fact that our retrospective 
study sample  comprised  of  subjects  visiting  STIs 
clinic,  DHQ  hospital, Faisalabad,  Pakistan,  where-
as,  previous  report  included  subjects  visiting  HCV 
screening camps and blood donors. Several national 
studies indicated high prevalence of  HCV infection in 
high risk groups. The prevalence of  HCV was signifi-
cantly higher (17.3%) in Rawalpindi than  in  Abbot-
tabad  (8%)  among  IDU23.   Kazi  et  al.24   determined 
15.2%  HCV  among Pakistani prisoners. Prevalence 
rates of  numerous sexually transmitted diseases in Fais-
alabad, Pakistan   have  already  been  documented26, 
rationalizing   the  probability   of   associated infections.
With about 50 years of  mean patient age in present 
study, it can be concluded that older age favours HCV 
infectivity rate. An observation supported by previous 
studies. Brian et al.,27 and Gaeta et al.,28 indicated that the 
proportion of  patients with clinically apparent hepatitis 
C increased with age. However, the increase in HCV 
cannot be explained solely by the effect of  aging in the 
general population. Pakistani society reflects health care 
negligence and delayed physician consultation26 and this 
may present an alternate explanation for the older age 
in present study.
Infected population attending STIs clinics had more 
men than women, indicative of  striking gender differ-
ence (2:1). This tendency can be explained by the fact 
that chances of  exposure to risk factors are more in 
men. Paladino et al.29 confirmed that the host's genetic 
background plays a significant role in the outcome of  
HCV infection. In particular, they demonstrated a gen-
der effect associated with the susceptibility to develop 
a persistent HCV infection. Nonetheless, other general 
or specified reasons not mentioned above to explain 
such effects should not be ignored. Present report doc-
umented that marital status and low literacy rates were 
associated with HCV (P<0.05). Low educational status 
is one of  the major barriers to disease treatment and 
management in the local population.26
Sexual  contact,  intravenous  and percutaneous  drug 
use and occupational,  habitual,  social behavior have 
been identified as risk factors for hepatitis transmission 
in various settings.18 
Present study identified injection drug use as the ma-
jor factor imperilling HCV infection. Current outcome 
about IDU was supported by Nelson et al.4 They de-
tected 60-80% hepatitis C prevalence in injection drug 
users (IDU). Similarly, in Russian IDU, HCV preva-
lence was 54-70%6  and 61.4%  among  Chinese  IDU7. 
Contrary  to that, higher  prevalence  of  HCV (97.3%) 
in IDU was found in Mauritius9.  However, IDU was 
never a significant factor for HCV incidence, as only 
0.2% and 6% HCV infectivity was noticed in Congo15 
and South- west Nigeria8.  Our results are not in accord-
ance with some of  the earlier data at domestic level, 
presenting 8-17.3% HCV prevalence in IDU in Abbot-
tabad and Rawalpindi.23
It is noteworthy that most of  the HCV positive patients 
claimed to be either IDU or blood donors and very few 
acknowledged their sexual trends as the causative factor 
for infectivity. Self- described patient’s history can be 
biased and should be considered with caution. 
Conclusion
The Hepatitis C viral infections are highly prevalent 
among the local population. Given the long term ex-
posure to risk factors, it is likely that injection drug us-
ers exhibit the highest proportions of  HCV serologi-
cal markers and indicate the urgent need for preventive 
strategies on intervention and facilitation of  access to 
healthcare programs. Furthermore, for monitoring con-
tagion  trends,  a period  of  two and half  year is not suf-
ficiently  long.  This data needs further observations.
Conflict of  interest statement
We declare that we have no conflict of  interest.
References
1.   Daw MA, Dau AA. Hepatitis C virus in Arab world: 
a state of  concern. Scientific World Journal 2012; 719494. 
http://www.ncbi.nlm.nih.gov/pubmed/22629189
2.   Anjum  S,  Ali  S,  Ahmad  T, Afzal  MS,  Wa-
heed  Y, Shafi  T,  et al.  Sequence  and structural 
analysis of  3' untranslated  region of  hepatitis C virus, 
genotype 3a, from Pakistani isolates. Hepat Mon 2013; 
13(5):e8390. http://www.ncbi.nlm.nih.gov/pmc/arti-
cles/PMC3732663
3.   Köse S, Kuzucu L, Gözaydın A, Yılmazer T. Preva-
lence of  hepatitis B and C viruses among asylum seek-
ers in Izmir. J Immigr Minor Health 2013.  
4.  Nelson PK, Mathers BM, Cowie B, Hagan H, Jarlais 
DD, Horyniak D, et al. Global epidemiology  of  hepati-
tis B and hepatitis C in people who inject drugs: results 
of  systematic reviews. Lancet 2011; 378(9791): 571-83. 
doi: 10.1016/S0140-6736(11)61097-0
5. Adjei  AA,  Quaye  IKE,  Armah  HB,  Hesse  IFA, 
Gbagbo  F,  Ampofo  WK,  et  al. Prevalence of  hu-
man immunodeficiency virus, hepatitis B virus, hepa-
titis C virus and syphilis  among  prison  inmates  and 
officers  at Nsawam  and Accra,  Ghana. J Med Micro-
biol 2006;55: 593-97. http://jmm.sgmjournals.org/con-
tent/55/5/593.short
6. Rhodes T, Platt L, Maximova S, Koshkina E, Lati-
shevskaya  N, Hickman M, et al. Prevalence of  HIV, 
hepatitis C and syphilis among injecting drug users in 
Russia: multi-city study. Addiction 2006;  101(2): 252-66. 
DOI: 10.1111/j.1360-  0443.2006.01317.x
7.   Xia  X,  Luo  J,  Bai  J,  Yu  R.  Epidemiology  of  
hepatitis  C  virus  infection  among injection  drug 
users  in China:  systematic  review  and meta-analysis. 
Public  health 2008;122(10):990-1003. http://www.scien-
                             812                   813    African Health Sciences Vol 14 Issue 4, December 2014 African Health Sciences Vol 14 Issue 4, December 2014



















Married vs. other status 












































































8.   Buseri FI, Muhibi MA, Jeremiah ZA. Sero-epidemi-
ology of  transfusion-transmissible infectious  diseases 
among  blood  donors  in  Osogbo,  south-west  Ni-
geria.  Blood Transfus 2009; 7(4): 293. http://www.ncbi.
nlm.nih.gov/pmc/articles/PMC2782806
9. Johnston L, Saumtally A, Corceal S, Mahadoo I, 
Oodally F. High HIV and hepatitis C prevalence 
amongst injecting drug users in Mauritius: Findings 
from a population size  estimation and respondent 
driven sampling survey. Int J Drug Policy 2011; 22(4):252-
58. http://www.sciencedirect.com/science/article/pii/
S0955395911000685
10. Nagalo  MB,  Sanou  M,  Bisseye  C,  Kaboré  MI, 
Nebie  YK,  Kienou  K,  et  al. Seroprevalence  of  
human  immunodeficiency  virus,  hepatitis  B and  C 
viruses  and  syphilis among blood donors in Koudou-
gou (Burkina Faso) in 2009. Blood Transfus 2011; 9(4): 
419-24. http://www.ncbi.nlm.nih.gov/pmc/articles/
PMC3200412/
11. Zhao  YS,  Su  SL,  Lv  CX,  Zhang  XF,  Lin  L, 
Sun  XG,  et  al.  Sero-prevalence  of  hepatitis C, hepa-
titis B virus and syphilis in HIV-1 infected patients in 
Shandong. Int J STD & AIDS 2012; 23: 639-43. doi: 
10.1258/ijsa.2012.011411
12. Calleja-Panero  JL, Llop-Herrera  E, Ruiz-Moraga 
M, de-la-Revilla-Negro  J, Calvo- Bonacho E, Pons-
Renedo F, et al. Prevalence of  viral hepatitis (B and C) 
serological markers in healthy working population. Rev 
Espn enferm dig 2013; 105(5), 249-54. http://www.ncbi.
nlm.nih.gov/pubmed/23971655
13. Johnston LG, Corceal S. Unexpectedly high injec-
tion drug use, HIV and hepatitis C prevalence  among 
female  sex workers  in the Republic  of   Mauritius. 
AIDS Behav 2013; 17(2):574-84. http://www.ncbi.nlm.
nih.gov/pubmed/22851154
14. Johnston LG, Vaillant TC, Dolores Y, Vales HM. 
HIV, hepatitis B/C and syphilis prevalence and risk 
behaviors among gay, transsexuals and men who have 
sex with men, Dominican Republic. Int J STD AIDS 
2013; 24(4):313-21.http://www.ncbi.nlm.nih.gov/pub-
med/23970664
15. Nzaji  MK,  Ilunga  BK.  A study  of   the  preva-
lence  of  infectious  markers  in blood donors in ru-
ral areas. The case of  Kamina hospital. Sante publique 
2013; 25(2): 213-17. http://europepmc.org/abstract/
MED/23964546
16. Tun W, Vu L, Adebajo SB, Abiodun L, Sheehy M, 
Karlyn A, et al. Population-based prevalence of  hepati-
tis B and C virus, HIV, syphilis, gonorrhoea  and chla-
mydia in male  injection  drug users in Lagos,  Nigeria. 
Int J STD AIDS 2013; 24(8):619-25. http://www.ncbi.
nlm.nih.gov/pubmed/23970571 
17. Zohrabyan L, Sultanov L, Demianenko  E, Vagaitse-
va N, Malkin J. P3. 097 Socio- demographic characteris-
tics and drug related high risk behaviour in people who 
inject drugs (PWID) Recently diagnosed HIV positive 
in Barnaul, Russia.Sex Transm Infec 2013; 89(Suppl 1), 
A177-A178. doi:10.1136/sextrans-2013-051184.0556
18. Gasim GI, Murad IA, Adam I. Hepatitis B and C 
virus infections among pregnant women in Arab and 
African countries. J Infect Dev Ctries 2013; 7(08):566-78. 
doi: 10.3855/jidc.3243
19. Noubiap JJN, Joko YWA, Nansseu JRN, Tene UG, 
Siaka C. Sero-epidemiology  of  human  immunodefi-
ciency  virus,  hepatitis  B and C viruses,  and syphi-
lis  infections among first-time blood donors in Edéa, 
Cameroon. Int J Infect Dis2013; 17(10):e832- e837. 
http://www.sciencedirect.com/science/article/pii/
S120197121201329X
20. Gacche RN, Kaid AM. Epidemiology of  viral 
hepatitis B and C infections in ibb city, Yemen. Hepat 
Mon 2012;12(7):460-62.http://www.ncbi.nlm.nih.gov/
pmc/articles/PMC3437458/
21. Zuberi SJ. Seroepidemiology of  HBV/HCV in Pa-
kistan. Int J Hepatol Commun 1996; 5(1):19-26.
http://www.sciencedirect.com/science/article/pii/
S0928434696820068
22. Ali  SA,  Donahue  RM,  Qureshi  H,  Vermund  SH. 
Hepatitis  B  and  hepatitis  C  in Pakistan: prevalence 
and risk factors. Int J Infec Diseases 2009; 13(1):9-19.             
http://www.sciencedirect.com/science/article/pii/
S1201971208014203
23. Platt L, Vickerman P, Collumbien M, Hasan S, Lalji 
N, Mayhew S, et al. Prevalence of   HIV,  HCV  and 
sexually  transmitted  infections  among  injecting  drug 
users  in Rawalpindi  and  Abbottabad,  Pakistan:  evi-
dence  for  an  emerging  injection-related HIV epidem-
ic. Sex transm infect 2009; 85(Suppl 2), ii17-ii22. http://
sti.bmj.com/content/85/Suppl_2/ii17.short
24. Kazi  AM,  Shah  SA,  Jenkins  CA,  Shepherd  BE, 
Vermund  SH.  Risk  factors  and prevalence of  tu-
berculosis, human immunodeficiency virus, syphilis, 
hepatitis B virus and hepatitis C virus among prisoners 
in Pakistan. Int J Infect Dis 2010; 14(Suppl 3): e60-e66. 
http://www.sciencedirect.com/science/article/pii/
S1201971210000305
25. Ahmad N, Asgher M, Shafique M, Qureshi JA. An 
evidence of  high prevalence of  Hepatitis C virus in 
Faisalabad, Pakistan. Saudi Med J 2007; 28 (3):390-95. 
http://www.ncbi.nlm.nih.gov/pubmed/17334466
26. Maan  MA,  Hussain  F,  Iqbal  J,  Akhtar  SJ.  Sexu-
ally  transmitted  infections  in Pakistan. Annals Saudi 
Med 2011; 31(3):263-69. http://www.ncbi.nlm.nih.gov/
pmc/articles/PMC3119966 
27. Brian JM, Alward  WLM,  Hall DB, Heyward  WL, 
Bender  TR, Francis  DP, et al. Acute hepatitis B vi-
rus infection: Relation of  age to the clinical expression 
of  disease and subsequent development of  the carrier 
state. J Infect Dis 1985; 151 (4):599-603. http://www.
ncbi.nlm.nih.gov/pubmed/3973412
28. Gaeta GB, Stornaiuolo G, Precone DF, Lobello S, 
Chiaramonte M, Stroffolini T, et al. Epidemiological 
and clinical  burden  of  chronic  hepatitis  B virus/
hepatitis  C virus infection. A multicenter Italian study. J 
Hepatol 2003; 39(6):1036-41. http://www.ncbi.nlm.nih.
gov/pubmed/14642623
29. Paladino N, Fainboim H, Theiler G, Schroder T, 
Muñoz AE, Flores AC, et al. Gender susceptibility  to 
chronic  hepatitis  C virus  infection  associated  with 
interleukin  10 promoter polymorphism. J Virol 2006; 
80:9144-50. http://jvi.asm.org/content/80/18/9144.
short
                             814         815    African Health Sciences Vol 14 Issue 4, December 2014 African Health Sciences Vol 14 Issue 4, December 2014
